{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"Fatty Liver, Fiercer Metastases, Future Targets \ud83e\uddec","description":"\ud83e\uddec New Nature study: fatty liver may do more than coexist with colorectal cancer liver metastases \u2014 it may shape their biology. Steatotic livers were linked to more aggressive \u201creplacement\u201d metastases, driven by fatty acid oxidation, MYC stabilization, proline synthesis, and collagen remodeling.&amp;nbsp; The practical pearl: liver-fat content may become a biomarker for prognosis and trial selection, especially for MYC-targeted therapy. Metabolism is not background noise \u2014 it may be the soil that scripts metastatic fate. \ud83c\udfaf ","author_name":"Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!","author_url":"http:\/\/www.MasterMedFacts.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41956465\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/203749165"}